BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21461713)

  • 1. Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.
    Hug K; Hermerén G
    Stem Cell Rev Rep; 2011 Nov; 7(4):761-74. PubMed ID: 21461713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Aspects of Translating Research with Human Pluripotent Stem Cell Products into Clinical Practice: A Stakeholder Approach.
    Heyder C; Hansen SL; Wiesemann C
    New Bioeth; 2020 Mar; 26(1):3-16. PubMed ID: 32072871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The embryonic stem cells research. Example of biotechnology progress under extra-scientific pressure].
    Gámez Escalona JA
    Cuad Bioet; 2013; 24(82):443-62. PubMed ID: 24483318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double vision.
    Nature; 2013 May; 497(7450):409. PubMed ID: 23936908
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical considerations in chimera research.
    Hermerén G
    Development; 2015 Jan; 142(1):3-5. PubMed ID: 25516962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.
    Condic ML; Rao M
    Stem Cells Dev; 2010 Aug; 19(8):1121-9. PubMed ID: 20397928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to depolarise the ethical debate over human embryonic stem cell research (and other ethical debates too!).
    Espinoza N; Peterson M
    J Med Ethics; 2012 Aug; 38(8):496-500. PubMed ID: 22375081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.
    Murdoch A; Braude P; Courtney A; Brison D; Hunt C; Lawford-Davies J; Moore H; Stacey G; Sethe S; ;
    Stem Cell Rev Rep; 2012 Mar; 8(1):91-9. PubMed ID: 21671059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ethics of stem cells revisited.
    de Miguel-Beriain I
    Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the microrheology of human embryonic stem cells and human induced pluripotent stem cells.
    Daniels BR; Hale CM; Khatau SB; Kusuma S; Dobrowsky TM; Gerecht S; Wirtz D
    Biophys J; 2010 Dec; 99(11):3563-70. PubMed ID: 21112280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field.
    Kobold S; Guhr A; Kurtz A; Löser P
    Stem Cell Reports; 2015 May; 4(5):914-25. PubMed ID: 25866160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The decision on the "optimal" human pluripotent stem cell.
    Rosner M; Schipany K; Hengstschläger M
    Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q&A: Stemming the tide of misinformation. Interview by Michael Eisenstein.
    Shevde N
    Nature; 2012 Feb; 483(7387):S27. PubMed ID: 22378126
    [No Abstract]   [Full Text] [Related]  

  • 16. Law, ethics, religion, and clinical translation in the 21st century.
    Trounson A
    Stem Cells; 2010 Jan; 28(1):2. PubMed ID: 19998372
    [No Abstract]   [Full Text] [Related]  

  • 17. SCIENTIFIC COMMUNITY. Confronting stem cell hype.
    Caulfield T; Sipp D; Murry CE; Daley GQ; Kimmelman J
    Science; 2016 May; 352(6287):776-7. PubMed ID: 27174977
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical issues in stem cell research and therapy.
    King NM; Perrin J
    Stem Cell Res Ther; 2014 Jul; 5(4):85. PubMed ID: 25157428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.
    Ebihara Y; Ma F; Tsuji K
    Int J Hematol; 2012 Jun; 95(6):610-6. PubMed ID: 22648827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human embryonic stem cell therapies for neurodegenerative diseases.
    Tomaskovic-Crook E; Crook JM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.